This study investigates advanced solid tumors. It looks at how an investigational medication works with other anti-tumor treatments.
The study evaluates the safety and tolerability of the investigational medication with chemotherapy. It checks how well these treatments can be handled by patients.
- Who can participate: Participants must be 18 years or older with advanced pancreatic cancer, have good organ function, and provide informed consent.
- Study details: Participants will receive an investigational medication combined with chemotherapy. A placebo may be used.
- Study timelines: The study will last 12 weeks.